Category: Notes to the SCC

Neuropsychopharmacology January 2018

The table of contents forwarded by Stephen Robinson, MD, reflects the Faustian Bargain made by leading researchers with respect to cannabis. No longer able to deny beneficial effects, they pay exaggerated attention to the possible harms, notably Cannabis Use Disorder. The editorial overview  by Drs. Margaret Haney and Matthew Hill provides an informative summary of ECS research, and can be downloaded in full. Unfortunately, many of the papers the authors summarize give the Devil —a card-carrying Prohibitionist— His due. For example “Outside of the role of endocannabinoids, however, cannabis itself is also a drug of abuse, and preclinical models...

Read More

Speller, Ragland Curtailed by MBC

The Medical Board of California earlier this year punished two physicians who specialized in cannabis consultations. The disposition of their cases as per the MBC website: SPELLER, CRISTAL DAWN, M.D. (A 62390), Glendale, CA No admission but charged with repeated negligent acts in the care and treatment of three patients when she approved phone renewals for marijuana without conducting an examination and violated the terms of her Board-ordered probation. Revoked, stayed, placed on 4 years’ probation to be served consecutively to previously imposed probation, with terms and conditions including, but not limited to, completing an education course, a prescribing practices...

Read More

New Hampshire to Dr. Konopka: ‘Computerize or Die’

As reported by Ars Technica’s Cyrus Farivar November 5: An 84-year-old doctor in New London, New Hampshire, appeared in state court Friday in an effort to regain her medical license, less than a week after closing her office on October 28. State authorities claim that—because Dr. Anna Konopka doesn’t have a computer, much less know how to use one—her organizational skills are lacking, according to the Associated Press. “The problem now is that I am not doing certain things on a computer,” she told the news service. “I have to learn that. It is time consuming. I have no...

Read More

ETOH Sales Drop in MMJ States

Alcoholic beverage sales fell by 15 percent in states that adopted medical marijuana laws (MMLs), according to a paper by researchers at the University of Connecticut and Georgia State University posted online at SSRN November 2. Here’s the abstract: We use data on purchases of alcoholic beverages in grocery, convenience, drug, or mass distribution stores in US counties for 2006-2015 to study the link between medical marijuana laws and alcohol consumption and focus on settling the debate between the substitutability or complementarity between marijuana and alcohol. To do this we exploit the differences in the timing of the of marijuana laws...

Read More

Cannabinoids for prevention of migraines

A study presented at the Congress of the European Academy of Neurology in Amsterdam confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments. Interestingly though, when it comes to treating acute cluster headaches they are only effective in patients that suffered from migraine in childhood. Amsterdam, 24 June 2017 – Germany’s recent decision to liberalise the use of cannabis for medical purposes has rekindled policy debate across Europe. While politics and health authorities continue to weigh up the pros and cons of this treatment method, researchers are constantly furthering scientific understanding...

Read More